@MISC{_targetaudience, author = {}, title = {Target Audience}, year = {} }
Share
OpenURL
Abstract
Radiologists, oncologists, and other select referring physicians such as internal medicine specialists with an interest in integrating cost-effective FDG-PET and PET-CT fusion techniques into their clinical armamentarium to refine the diagnosis, staging, and effective clinical management of lung cancer, rectal and colorectal cancers, lymphoma, ovarian cancers, and other malignancies. Goal The objective of this activity is to spotlight the clinical impact and cost-effectiveness of advanced imaging studies such as FDG-PET scanning and PET-CT fusion studies in the detection and management of cancer, define the peak clinical applications for the successful use of these technologies, and provide a venue for an expert to detail the benefit of these technologies for the radiology, oncology, internal medicine, and other relevant clinical audiences on Medscape. Learning Objectives Upon completion of this activity, participants will be able to: 1. Detail the impact of FDG-PET and PET-CT studies on the detection, staging, and clinical management of a host of cancers. 2. Describe instances in which FDG-PET scanning is cost-effective because the modality can